BASF & vitamin C
This article was originally published in The Tan Sheet
Executive Summary
Company to shut down crystalline vitamin C line at Wilmington, N.C. facility by July 2002 but will continue to run vitamin C granulating, packaging operations at the site, ingredient supplier says Nov. 15. Move is aimed at strengthening BASF's market position by concentrating vitamin C manufacturing efforts "on areas that deliver better cost competitiveness and economies of scale," company says. BASF acquired the Wilmington site in January through its purchase of Takeda Chemical Industries' bulk vitamin business (1"The Tan Sheet" Aug. 7, 2000, p. 9)...
You may also be interested in...
BASF Global Vitamin Presence Strengthened With Takeda Combination
BASF's agreement to combine its bulk vitamins business with that of Takeda Chemical Industries considerably strengthens the chemical giant's position in the global vitamins market.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.
Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says
Updated draft guidance on promotion of biologic reference products, biosimilars and interchangeable biosimilars offers another indication of the US’s push to do away with the interchangeability designation.